Exciting new advances in oral cancer diagnosis: Avenues to early detection

Head and Neck Oncology

Volumn 3, Issue 1, 2011, Pages

  Mehrotra, Ravi ^a   Gupta, Dwijendra K ^b,c  

^a MLN MEDICAL COLLEGE   (India)

^b UNIVERSITY OF ALLAHABAD   (India)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Biomarkers; Brush Biopsy; Diagnosis; DNA; Oral Cancer; Saliva; Spectroscopy

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TOLONIUM CHLORIDE;

AUTOFLUORESCENCE; BIOPSY TECHNIQUE; CANCER DIAGNOSIS; CANCER SCREENING; CHEMOLUMINESCENCE; CLINICAL ASSESSMENT TOOL; CYTODIAGNOSIS; CYTOMETRY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFUSE REFLECTANCE SPECTROSCOPY; DNA IMAGE CYTOMETRY; DYSPLASIA; EARLY DIAGNOSIS; EXFOLIATIVE CYTOLOGY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FLUORESCENCE ANALYSIS; HUMAN; LASER CAPTURE MICRODISSECTION; MEDICAL INSTRUMENTATION; MICROFLUIDIC ANALYSIS; MICROSCOPE; MOUTH CANCER; MOUTH CAVITY; MOUTH LESION; MULTISPECTRAL DIGITAL MICROSCOPE; NON INVASIVE MEASUREMENT; OBSERVER VARIATION; OPTICAL COHERENCE TOMOGRAPHY; ORAL BRUSH BIOPSY; ORAL DYSPLASIA; ORAL SQUAMOUS CELL CARCINOMA; PLOIDY; PRECANCER; PRIORITY JOURNAL; REVIEW; SALIVA ANALYSIS; SCALPEL BIOPSY; SPECTRAL CYTOPATHOLOGY; SQUAMOUS CELL CARCINOMA; STAINING; GENETICS; MASS SCREENING; METHODOLOGY; MOUTH TUMOR; PATHOLOGY; PROGNOSIS;

CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; HUMANS; MASS SCREENING; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; PROGNOSIS;

EID: 79960654202     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-3-33     Document Type: Review

References (53)

1. Cancer Statistics 2010. Jemal A, Siegel R, Xu J, Ward E, CA Cancer J Clin 2010 60 277 300 10.3322/caac.20073 20610543
2. Trivandrum Oral Cancer Screening Study Group. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, Rajan B, Lancet 2005 365 9475 1927 33 10.1016/S0140-6736(05)66658-5 15936419 (Pubitemid 40797502)
3. Screening programmes for the early detection and prevention of oral cancer. Kujan O, Glenny AM, Oliver RJ, Thakker N, Sloan P, Cochrane Database Syst Rev 2006 3 D004150 16856035
4. SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. 2008 http://seer.cancer.gov/csr/1975-2005/ based on November 2007 SEER data submission, posted to the SEER web site
5. http://www.ada.org/2607.aspx
6. Oral cytology revisited. Mehrotra R, Hullmann M, Smeets R, Reichert TE, Driemel O, J Oral Pathol Med 2009 38 161 6 19213102
7. Cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, Shukla P, J Am Dent Assoc 2010 141 151 6 20123872
8. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. Sciubba JJ, J Am Dent Assoc 1999 130 1445 57 10570588
9. The sensitivity and specificity of the oral CDx technique: evaluation of 103 cases. Scheifele C, Schmidt-Westhausen AM, Dietrich T, Reichart A, Oral Oncol 2004 40 824 8 10.1016/j.oraloncology.2004.02.004 15288838 (Pubitemid 39061099)
10. Utility of toluidine blue and oral brush biopsy in oral precancerous lesions and squamous cell carcinoma. Gupta A, Singh M, Ibrahim R, Mehrotra R, Acta Cytol 2007 51 788 94 10.1159/000325843 17910350 (Pubitemid 47443614)
11. Oral premalignant lesions: is biopsy reliable? Holmstrup P, Vedtofte P, Reibel J, Stoltze K, J Oral Path Med 2007 36 262 6 10.1111/j.1600-0714.2007. 00513.x (Pubitemid 46632607)
12. Artefacts produced by suture traction during incisional biopsy of oral lesions. Seoane J, Varela-Centelles P, Ramirez JR, Romero MA, De La Cruz A, Clin Otolaryngol 2002 27 549 53 10.1046/j.1365-2273.2002.00619.x 12472529 (Pubitemid 36042884)
13. Avoiding artefacts in oral biopsies: the punch biopsy versus the incisional biopsy. Moule L, Parsons PA, Irvine GH, Br J Maxillofac Surg 1995 33 244 7 10.1016/0266-4356(95)90010-1
14. Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma. Kusukawa J, Suefuji Y, Ryu F, Noguchi R, Iwamoto O, Kameyama T, J Oral Pathol Med 2000 29 303 7 10.1034/j.1600-0714. 2000.290703.x 10947245 (Pubitemid 30459301)
15. Reverse transcriptase polymerase chain reaction study to evaluate dissemination of cancer cells into circulation after incision biopsy in oral squamous cell carcinoma. Dyavanagoudar S, Kale A, Bhat K, Hallikerimath S, Indian J Dent Res 2008 19 315 9 10.4103/0970-9290.44534 19075434
16. The use of the carbon dioxide laser in plastic surgery. Klein DR, South Med J 1977 70 429 31 10.1097/00007611-197704000-00018 322307 (Pubitemid 8108259)
17. Factors associated with underdiagnosis from incisional biopsy of oral leukoplakic lesions. Lee JJ, Hung HC, Cheng SJ, Chiang CP, Liu BY, Yu CH, Jeng JH, Chang HH, Kok SH, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 104 2 217 25 10.1016/j.tripleo.2007.02.012 17560138
18. Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Woolgar JA, Triantafyllou A, Oral Oncol 2009 45 361 85 10.1016/j.oraloncology.2008.07.016 18849188
19. Malignancy trading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. Bryne M, Koppang H, Lilleng R, Kjaerhheim A, J Pathol 1992 166 375 81 10.1002/path.1711660409 1517891
20. Toluidine blue. Mashberg A, J Can Dent Assoc 1995 61 11 922 944 8521318
21. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Martin IC, Kerawala CJ, Reed M, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 85 4 444 6 10.1016/S1079-2104(98) 90071-3 9574954 (Pubitemid 128645222)
22. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions. Epstein JB, Güneri P, Curr Opin Otolaryngol Head Neck Surg 2009 17 2 79 87 10.1097/MOO.0b013e32832771da 19374030
23. Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions. Mehrotra R, Gupta A, Singh M, Ibrahim R, Mol Cancer 2006 5 1 11 16403226
24. Immuno-LCM: Laser capture micro dissection of immunostained frozen sections for mRNA analysis. Fend F, Emmert-Buck MR, Chuaqui R, Cole K, Lee J, Liotta LA, Raffeld M, Am J Pathol 1999 154 61 6 10.1016/S0002-9440(10)65251-0 9916919 (Pubitemid 29031612)
25. Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK. He H, Sun G, Ping F, Artif Cells Blood Substit Immobil Biotechnol 2009 37 5 208 13 10.1080/10731190903199028 19735007
26. Recent advances in understanding carcinogenicity of oral squamous cell carcinoma: from basic molecular biology to latest genomic and proteomic findings. Mehrotra R, Vasstrand EN, Ibrahim SO, Cancer Genomics Proteomics 2004 1 283 94
27. Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma. Bradley G, Odell EW, Raphael S, Ho J, Le LW, Benchimol S, Kamel-Reid S, Br J Cancer 2010 103 9 1432 42 10.1038/sj.bjc.6605905 20859287
28. Cytologic and DNA cytometric very early diagnosis of oral cancer. Maraki D, Becker J, Boecking A, J Oral Pathol Med 2004 33 398 404 10.1111/j.1600-0714. 2004.0235.x 15250831 (Pubitemid 38988194)
29. Cytologic and DNA-cytometric examination of oral lesions in lichen planus. Maraki D, Yalcinkaya S, Pomjanski N, Megahed M, Boecking A, Becker J, J Oral Pathol Med 2006 35 4 227 32 10.1111/j.1600-0714.2006.00401.x 16519770 (Pubitemid 43362954)
30. Additional use of DNA-image cytometry improves the assessment of resection margins. Handschel J, Oz D, Pomjanski N, Depprich R, Ommerborn MA, Braunstein S, Kübler NR, Meyer U, Böcking A, J Oral Pathol Med 2007 36 8 472 5 10.1111/j.1600-0714.2007.00564.x 17686005 (Pubitemid 47222105)
31. Noninvasive brush biopsy as an innovative tool for early detection of oral carcinomas. Remmerbach TW, Mathes SN, Weidenbach H, Hemprich A, Böcking A, Mund Kiefer Gesichtschir 2004 8 4 229 36 15293118
32. Toward a multimodal cell analysis of brush biopsies for the early detection of oral cancer. Remmerbach TW, Meyer-Ebrecht D, Aach T, Würflinger T, Bell AA, Schneider TE, Nietzke N, Frerich B, Böcking A, Cancer Cytopathol 2009 117 3 228 35 10.1002/cncy.20028
33. Oral cancer diagnosis by mechanical phenotyping. Remmerbach TW, Wottawah F, Dietrich J, Lincoln B, Wittekind C, Guck J, Cancer Res 2009 69 5 1728 32 10.1158/0008-5472.CAN-08-4073 19223529
34. Detection of non-diploid cells in premalignant and malignant oral lesions using combined morphological and FISH analysis-a new method for early detection of suspicious oral lesions. Hirshberg A, Yarom N, Amariglio N, Yahalom R, Adam I, Stanchescu R, Ben-Dov I, Taicher S, Rechavi G, Trakhtenbrot L, Cancer Lett 2007 253 2 282 90 10.1016/j.canlet.2007.02.008 17386971 (Pubitemid 47017541)
35. Screening for oral precancer with noninvasive genetic cytology. Bremmer JF, Graveland AP, Brink A, Braakhuis BJ, Kuik DJ, Leemans CR, Bloemena E, van der Waal I, Brakenhoff RH, Cancer Prev Res (Phila) 2009 2 2 128 33 10.1158/1940-6207.CAPR-08-0128
36. Saliva as a tool for oral cancer diagnosis and prognosis. Nagler RM, Oral Oncol 2009 45 1006 10 10.1016/j.oraloncology.2009.07.005 19828359
37. Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Bahar G, Feinmesser R, Popovtzer A, Nagler RM, Cancer 2007 109 1 54 9 10.1002/cncr.22386 17099862 (Pubitemid 46120194)
38. Salivary transcriptome diagnostics for oral cancer detection. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, Wong DT, Clin Cancer Res 2004 10 8442 50 10.1158/1078-0432.CCR-04-1167 15623624 (Pubitemid 40053408)
39. A comprehensive salivary analysis for oral cancer diagnosis. Shpitzer T, Bahar G, Feinmesser R, Nagler RM, J Cancer Res Clin Oncol 2007 133 9 613 7 10.1007/s00432-007-0207-z 17479291 (Pubitemid 47077052)
40. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients. Zhong LP, Zhang CP, Zheng JW, Li J, Chen WT, Zhang ZY, Arch Oral Biol 2007 52 11 1079 87 10.1016/j.archoralbio.2007.05.005 17612501 (Pubitemid 47503114)
41. Salivary mRNA targets for cancer diagnostics. Zimmermann BG, Wong DT, Oral Oncol 2008 44 5 425 9 10.1016/j.oraloncology.2007.09.009 18061522 (Pubitemid 351608624)
42. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth V, Bell JI, Proc Natl Acad Sci USA 1992 89 12160 4 10.1073/pnas.89.24.12160 1465456 (Pubitemid 23004805)
43. Lab-on-a-chip for oral cancer screening and diagnosis. Ziober BL, Mauk MG, Falls EM, Chen Z, Ziober AF, Bau HH, Head Neck 2008 30 1 111 21 10.1002/hed.20680 17902150 (Pubitemid 351158328)
44. Cytopathology by optical methods: spectral cytopathology of the oral mucosa. Papamarkakis K, Bird B, Bedrossian M, Laver N, Wein R Diem M, Lab Invest 2010 90 4 589 98 10.1038/labinvest.2010.1 20142808
45. Multispectral optical imaging device for in vivo detection of oral neoplasia. Roblyer D, Richards-Kortum R, Sokolov K, El-Naggar AK, Williams MD, Kurachi C, Gillenwater AM, J Biomed Opt 2008 13 2 024019 10.1117/1.2904658 18465982
46. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, Berean KW, Ng S, Tseng OL, MacAulay C, Rosin MP, Clin Cancer Res 2006 12 22 6716 22 10.1158/1078-0432.CCR-06-1317 17121891 (Pubitemid 44876840)
47. In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: A pilot study. Vedeswari CP, Jayachandran S, Ganesan S, Indian J Dent Res 2009 20 3 261 7 10.4103/0970-9290.57354 19884705
48. Fluorescence spectroscopy for the detection of tongue carcinoma - validation in an animal model. Kurachi C, Fontana CR, Rosa LE, Bagnato VS, J Biomed Opt 2008 13 3 034018 10.1117/1.2937214 18601563
49. Nonlinear pattern recognition for laser-induced fluorescence diagnosis of cancer. Majumder SK, Majumder SK, Ghosh N, Kataria S, Gupta PK, Lasers Surg Med 2003 33 1 48 56 10.1002/lsm.10191 12866121 (Pubitemid 36927776)
50. Oxygenated hemoglobin diffuse reflectance ratio for in vivo detection of oral pre-cancer. Mallia R, Thomas SS, Mathews A, Kumar R, Sebastian P, Madhavan J, Subhash N, J Biomed Opt 2008 13 4 041306 10.1117/1.2952007 19021314 (Pubitemid 351987911)
51. Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, Gillenwater A, Clin Cancer Res 2008 14 8 2396 404 10.1158/1078-0432.CCR-07-1609 18413830 (Pubitemid 351551073)
52. Enhanced detection of early-stage oral cancer in vivo by optical coherence tomography using multimodal delivery of gold nanoparticles. Kim CS, Wilder-Smith P, Ahn YC, Liaw LH, Chen Z, Kwon YJ, J Biomed Opt 2009 14 3 034008 10.1117/1.3130323 19566301
53. In vitro examination of suspicious oral lesions using optical coherence tomography. Jerjes W, Upile T, Conn B, Betz CS, McKenzie G, Radhi H, Vourvachis M, El Maaytah M, Sandison A, Jay A, Hopper C, Br J Oral Maxillofac Surg 2010 48 18 25 10.1016/j.bjoms.2009.04.019 19726114